Diagante develops the TISSUtainer®, a preanalytical in vitro diagnostic device that preserves and processes solid clinical specimens, ensuring sample integrity for accurate analysis. This technology addresses the challenge of low detection rates in bone and joint infections, achieving a sensitivity of 95% and specificity of 99% to enhance diagnostic performance in orthopedic practices.
Funding
Funding not disclosed
Founders
Product
Problem
Current methods for processing solid clinical specimens often compromise sample integrity, leading to inaccurate diagnostic results, particularly in bone and joint infections where detection rates can be suboptimal. This can result in delayed or incorrect diagnoses, impacting patient outcomes and requiring repeat procedures.
Solution
Diagante offers the TISSUtainer®, a preanalytical in vitro diagnostic (IVD) medical device designed to preserve and process solid tissue samples, ensuring sample integrity from collection to analysis. The TISSUtainer® utilizes a programmable nanomaterial to preserve and process solid samples, enabling rapid and high-throughput diagnosis on solid tissues. By protecting the vitality of infecting organisms and facilitating their release from solid tissues, the TISSUtainer® enhances the accuracy of diagnostic tests. The device integrates with existing clinical and laboratory workflows, providing a streamlined solution for improved diagnostic performance.
Target Audience
The primary target audience includes orthopedic surgeons and clinical laboratories seeking to improve the accuracy and efficiency of solid tissue diagnostics, particularly in the detection of bone and joint infections.
Features
- Programmable nanomaterial for preservation and processing of solid samples
- High-performance extraction capabilities for effective pathogen recovery
- Sealed bottle design to maintain sample integrity and prevent contamination
- Streamlined workflow integration with current clinical and laboratory practices
- Demonstrated sensitivity of 95% and specificity of 99% in detecting bone and joint infections